Covid-19 management and pharma

I’m curious why no management about covid-19 is included in the step 1/2 deck. Was this a deliberate decision due to changing guidelines?. I’m based in UK and the guidelines for managing covid in community and hospital is fairly well established.

It would be nice to have just a few cards that define what drugs are being used. I have attached current WHO document as source if anyone wants to read and will also link in case the screenshot doesn’t load.

Guideline Therapeutics and COVID-19: living guideline (who.int)
-Page 14 has good infographic.

We do not add information that is not tested in board resources. When creating new cards or considering adding information, if it is not mentioned in a UWorld question / NBME / AMBOSS question then we do not include it if its not relevant to the Step exams.

This deck is for Step 1/2/3, and we use those resources mentioned above to consider what is now relevant to add.

1 Like